The Ameridose opportunity
Buoyed by NECC's success, in 2006 Mr. Cadden and Greg Conigliaro
decided to take advantage of another opportunity. Hospital com-
pounding pharmacies were overloaded with work filling IV bags and
syringes. At least 2 companies, Central Admixture Pharmacies (CAPS)
and Pharmedium, were already successfully providing outsourcing
services. The newest Cadden-Conigliaro company, Ameri dose, would
focus on this business. Based in the same industrial complex along
with the recycling facility, Ameridose could fill IV bags with hundreds
of different meds, including antibiotics, cholinergics, hep arin and the
like. Ameridose offered syringe-filling, too. The Ameridose web page
invited hospitals to free up their pharmacy staff to focus on outcomes
and patient safety. It said hospitals could be totally confident because
the company used the strictest standards. The experienced pharma-
cists were well versed in state laws, FDA and DEA regulations, cGMP
requirements and USP Chapter 797.
J U L Y 2 0 1 6 • O U T PA T I E N TS U R G E R Y. N E T • 1 5 1
• FUNGAL OUTBREAK Shawn Lockhart looks at the meningitis-causing fungus Exserohilum rostratum at the mycotic lab at the Centers for Disease Control and Prevention.
